Literature DB >> 21910124

Cranberries: ripe for more cancer research?

Catherine C Neto1.   

Abstract

Berries have been recognized as a functional food with potential to protect against a variety of health conditions, including some cancers. Cranberry (Vaccinium macrocarpon) production and consumption have grown in recent years, warranting further evaluation of potential health benefits. Extracts and isolated constituents from cranberry fruit inhibit growth and proliferation of tumor cells in vitro, and recent data from animal studies lend further support to cranberry's reputation as a cancer fighter. Several likely mechanisms of action for cranberry against prostate and other cancers have been identified, including induction of apoptosis and inhibition of events linked to cellular invasion and migration. This article attempts to put into perspective what is known about cranberry's potential chemopreventive properties, what is yet to be determined, and some factors to consider as research moves forward.
Copyright © 2011 Society of Chemical Industry.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21910124     DOI: 10.1002/jsfa.4621

Source DB:  PubMed          Journal:  J Sci Food Agric        ISSN: 0022-5142            Impact factor:   3.638


  9 in total

1.  Upper esophageal and pharyngeal cancers.

Authors:  Jonathan M Bock; Amy B Howell; Nikki Johnston; Laura A Kresty; Daniel Lew
Journal:  Ann N Y Acad Sci       Date:  2014-09       Impact factor: 5.691

2.  Stability of Polyphenols Epigallocatechin Gallate and Pentagalloyl Glucose in a Simulated Digestive System.

Authors:  Melanie A Krook; Ann E Hagerman
Journal:  Food Res Int       Date:  2012-08-04       Impact factor: 6.475

3.  The American cranberry: first insights into the whole genome of a species adapted to bog habitat.

Authors:  James Polashock; Ehud Zelzion; Diego Fajardo; Juan Zalapa; Laura Georgi; Debashish Bhattacharya; Nicholi Vorsa
Journal:  BMC Plant Biol       Date:  2014-06-13       Impact factor: 4.215

4.  Cranberry extract standardized for proanthocyanidins promotes the immune response of Caenorhabditis elegans to Vibrio cholerae through the p38 MAPK pathway and HSF-1.

Authors:  Jessica Dinh; Joseph T Angeloni; Daniel B Pederson; Xiaoxia Wang; Min Cao; Yuqing Dong
Journal:  PLoS One       Date:  2014-07-25       Impact factor: 3.240

5.  Cranberry proanthocyanidins inhibit esophageal adenocarcinoma in vitro and in vivo through pleiotropic cell death induction and PI3K/AKT/mTOR inactivation.

Authors:  Laura A Kresty; Katherine M Weh; Bree Zeyzus-Johns; Laura N Perez; Amy B Howell
Journal:  Oncotarget       Date:  2015-10-20

6.  Addition of cranberry to proton pump inhibitor-based triple therapy for Helicobacter pylori eradication.

Authors:  Mohammadreza Seyyedmajidi; Anahita Ahmadi; Shahin Hajiebrahimi; Seyedali Seyedmajidi; Majid Rajabikashani; Mona Firoozabadi; Jamshid Vafaeimanesh
Journal:  J Res Pharm Pract       Date:  2016 Oct-Dec

Review 7.  Phytochemicals and Gastrointestinal Cancer: Cellular Mechanisms and Effects to Change Cancer Progression.

Authors:  Raghad Khalid Al-Ishaq; Anthony J Overy; Dietrich Büsselberg
Journal:  Biomolecules       Date:  2020-01-08

8.  Effect of cranberry dietary supplements with different brands on human CYP3A4 enzyme.

Authors:  Sompon Wanwimolruk; Supaluk Prachayasittikul; Virapong Prachayasittikul; Bouchra Bernichi
Journal:  EXCLI J       Date:  2012-03-28       Impact factor: 4.068

9.  Phytochemical analysis and protective effects of Vaccinium macrocarpon (cranberry) in rats (Rattus norvegicus) following ethylene oxide-induced oxidative insult.

Authors:  Mahmood Rasool; Arif Malik; Muhammad Abdul Basit Ashraf; Rabia Mubbin; Ujala Ayyaz; Sulayman Waquar; Muhammad Asif; Muhammad Umar; Gan Siew Hua; Zafar Iqbal; Hina Alam; Niaz M Achakzai
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.